vaccine

Sequoia announces Fast Track Status granted by FDA

Sequoia announces Fast Track Status granted by FDA

"Many of my patients with multidrug-resistant recurrent urinary tract infections have tried multiple antibiotics for years without success," said Liz D'Antonio, CRNP, director of clinical research, Anne Arundel Urology. " A vaccine presents a new approach that could offer new hope for these patients. We eagerly await the results of the next studies as it hopefully moves toward approval."